Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain.

Higginson EE, Ramachandran G, Hazen TH, Kania DA, Rasko DA, Pasetti MF, Levine MM, Tennant SM.

mSphere. 2018 Nov 28;3(6). pii: e00474-18. doi: 10.1128/mSphere.00474-18.

2.

Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.

Higginson EE, Ramachandran G, Panda A, Shipley ST, Kriel EH, DeTolla LJ, Lipsky M, Perkins DJ, Salerno-Goncalves R, Sztein MB, Pasetti MF, Levine MM, Tennant SM.

Infect Immun. 2018 Nov 20;86(12). pii: e00440-18. doi: 10.1128/IAI.00440-18. Print 2018 Dec.

PMID:
30249748
3.

Deletions in guaBA and htrA but not clpX or rfaL constitute a live-attenuated vaccine strain of Salmonella Newport to protect against serogroup C2-C3 Salmonella in mice.

Fuche FJ, Jones JA, Ramachandran G, Higginson EE, Simon R, Tennant SM.

Hum Vaccin Immunother. 2018 Jun 21:1-9. doi: 10.1080/21645515.2018.1491499. [Epub ahead of print]

PMID:
29927725
4.

Virulence of invasive Salmonella Typhimurium ST313 in animal models of infection.

Ramachandran G, Panda A, Higginson EE, Ateh E, Lipsky MM, Sen S, Matson CA, Permala-Booth J, DeTolla LJ, Tennant SM.

PLoS Negl Trop Dis. 2017 Aug 4;11(8):e0005697. doi: 10.1371/journal.pntd.0005697. eCollection 2017 Aug.

5.

Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.

Baliban SM, Yang M, Ramachandran G, Curtis B, Shridhar S, Laufer RS, Wang JY, Van Druff J, Higginson EE, Hegerle N, Varney KM, Galen JE, Tennant SM, Lees A, MacKerell AD Jr, Levine MM, Simon R.

PLoS Negl Trop Dis. 2017 Apr 7;11(4):e0005493. doi: 10.1371/journal.pntd.0005493. eCollection 2017 Apr.

6.
7.

Animal Models for Salmonellosis: Applications in Vaccine Research.

Higginson EE, Simon R, Tennant SM.

Clin Vaccine Immunol. 2016 Sep 6;23(9):746-56. doi: 10.1128/CVI.00258-16. Print 2016 Sep. Review.

8.

Opsonophagocytic Assay To Evaluate Immunogenicity of Nontyphoidal Salmonella Vaccines.

Ramachandran G, Boyd MA, MacSwords J, Higginson EE, Simon R, Galen JE, Pasetti MF, Levine MM, Tennant SM.

Clin Vaccine Immunol. 2016 Jun 6;23(6):520-523. doi: 10.1128/CVI.00106-16. Print 2016 Jun.

9.

Salmonella Typhimurium Co-Opts the Host Type I IFN System To Restrict Macrophage Innate Immune Transcriptional Responses Selectively.

Perkins DJ, Rajaiah R, Tennant SM, Ramachandran G, Higginson EE, Dyson TN, Vogel SN.

J Immunol. 2015 Sep 1;195(5):2461-71. doi: 10.4049/jimmunol.1500105. Epub 2015 Jul 22.

10.

The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli.

Baldi DL, Higginson EE, Hocking DM, Praszkier J, Cavaliere R, James CE, Bennett-Wood V, Azzopardi KI, Turnbull L, Lithgow T, Robins-Browne RM, Whitchurch CB, Tauschek M.

Infect Immun. 2012 Jun;80(6):2042-52. doi: 10.1128/IAI.06160-11. Epub 2012 Mar 26.

Supplemental Content

Loading ...
Support Center